Risk Factors

Use of kidneys from trypanosoma cruzi-infected donors in naive transplant recipients without prophylactic therapy: the experience in a high-risk area.

Cicora F, Escurra V, Silguero S, Gonzalez IM, Roberti JE. Use of kidneys from trypanosoma cruzi-infected donors in naive transplant recipients without prophylactic therapy: the experience in a high-risk area. Transplantation// Transplantation. 2014;97(1):e3-4.

Serologic survey for exposure following fatal Balamuthia mandrillaris infection.

Jackson BR, Kucerova Z, Roy SL, Aguirre G, Weiss J, Sriram R, et al. Serologic survey for exposure following fatal Balamuthia mandrillaris infection. Parasitology research// Parasitol Res. 2014;113(4):1305-11.

Physiologic strategies to prevent fainting responses during or after whole blood donation.

Wieling W, France CR, van Dijk N, Kamel H, Thijs RD, Tomasulo P. Physiologic strategies to prevent fainting responses during or after whole blood donation. Transfusion. 2011;51(12):2727-38.

Upper-extremity deep venous thrombosis complicating whole-blood donation.

Covin RB, Rich NL, Aysola A. Upper-extremity deep venous thrombosis complicating whole-blood donation. Transfusion. 2004;44(4):586-90.

Donor-derived transmission events in 2013: a report of the Organ Procurement Transplant Network Ad Hoc Disease Transmission Advisory Committee.

Green M, Covington S, Taranto S, Wolfe C, Bell W, Biggins SW, et al. Donor-derived transmission events in 2013: a report of the Organ Procurement Transplant Network Ad Hoc Disease Transmission Advisory Committee. Transplantation. 2015;99(2):282-7.

Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic-uremic syndrome.

Rizvi MA, Vesely SK, George JN, Chandler L, Duvall D, Smith JW, et al. Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic-uremic syndrome. Transfusion. 2000;40(8):896-901.

Risks of hemolysis due to anti-A and anti-B caused by the transfusion of blood or blood components containing ABO-incompatible plasma.

Berseus O, Boman K, Nessen SC, Westerberg LA. Risks of hemolysis due to anti-A and anti-B caused by the transfusion of blood or blood components containing ABO-incompatible plasma. Transfusion. 2013;53 Suppl 1:114S-123S.

Transfusion-related acute lung injury: incidence and risk factors.

Toy P, Gajic O, Bacchetti P, Looney MR, Gropper MA, Hubmayr R, et al. Transfusion-related acute lung injury: incidence and risk factors. Blood//Blood. 2012;119(7):1757-67.

Transfusion-transmitted bacterial infection in the United States, 1998 through 2000.

Kuehnert MJ, Roth VR, Haley NR, Gregory KR, Elder KV, Schreiber GB, et al. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion//Transfusion. 2001;41(12):1493-9.

New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation.

Daikeler T, Labopin M, Ruggeri A, Crotta A, Abinun M, Hussein AA, et al. New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation. Blood//Blood. 2013;121(6):1059-64.

Pages